p38 MAPK Inhibition Mitigates Hypoxia-Induced AR Signaling in Castration-Resistant Prostate Cancer.
Serina CheungPallavi JainJonathan SoSaeid ShahidiStephen ChungMarianne KoritzinskyPublished in: Cancers (2021)
These results suggest that p38 MAPK inhibition may represent a therapeutic strategy to disrupt AR signaling in the heterogeneous CRPC tumor microenvironment.
Keyphrases